Clincosm LogoSign in Get a demo

Alzheimer's Disease

Showing NaN - NaN of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer's Disease Trial in Worldwide (GSK4527226, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • San Diego, California
  • +99 more
Oct 6, 2023

Alzheimer's Disease Trial in Worldwide (PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg)

Completed
Has Results
  • Alzheimer's Disease
  • PF-04360365 0.1 mg/kg
  • +5 more
  • Peoria, Arizona
  • +41 more
Oct 11, 2022

BEAM: Brain-Eye Amyloid Memory Study

Recruiting
  • Alzheimer's Disease
  • +4 more
  • Pittsburgh Compound B [11C]-PIB
  • Toronto, Ontario, Canada
  • +4 more
Oct 24, 2022

Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)

Recruiting
  • Alzheimer's Disease
  • Placebo
  • Bepranemab
  • Sun City, Arizona
  • +115 more
Aug 18, 2022

Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)

Completed
Has Results
  • Alzheimer's Disease
  • Sun City, Arizona
  • +130 more
May 23, 2022

Alzheimer's Disease Trial in Worldwide (Aducanumab)

Active, not recruiting
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +296 more
May 12, 2022

Alzheimer's Disease Trial in Canada (Perindopril, Telmisartan)

Recruiting
  • Alzheimer's Disease
  • Calgary, Alberta, Canada
  • +9 more
May 3, 2022

Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

Terminated
Has Results
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +132 more
Feb 16, 2022

Alzheimer's Disease Trial in Worldwide (Gantenerumab, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +138 more
Dec 10, 2021

Alzheimer's Disease Trial in Worldwide (ABBV-8E12)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +56 more
Nov 15, 2021

Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Aducanumab (BIIB037)
  • Placebo
  • Phoenix, Arizona
  • +180 more
Aug 9, 2021

Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Aducanumab (BIIB037)
  • Placebo
  • Birmingham, Alabama
  • +179 more
Aug 9, 2021

Alzheimer's Disease Trial in Worldwide (ABT-126)

Terminated
  • Alzheimer's Disease
  • Long Beach, California
  • +38 more
Jul 29, 2021

Alzheimer's Disease, Dementia Trial in Toronto, Riga (drug, genetic, other, behavioral)

Active, not recruiting
  • Alzheimer's Disease
  • Dementia
  • Spinal anesthesia group: bupivacaine 10-15mg
  • +4 more
  • Toronto, Ontario, Canada
  • +2 more
May 31, 2021

Alzheimer's Disease Trial in Canada, United States (Azeliragon 5mg)

Terminated
Has Results
  • Alzheimer's Disease
  • Azeliragon 5mg
  • Phoenix, Arizona
  • +70 more
May 28, 2021

Alzheimer's Disease Trial in Worldwide (Azeliragon, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +114 more
May 6, 2021

Alzheimer's Disease, Alzheimer Dementia (AD), Aggression Trial in Canada (Non-Pharmacological Intervention, Pharmacological

Recruiting
  • Alzheimer's Disease
  • +2 more
  • Non-Pharmacological Intervention
  • Pharmacological Intervention
  • Calgary, Alberta, Canada
  • +5 more
Mar 15, 2021

Alzheimer's Disease Trial in Worldwide (CAD106, Placebo, Alum)

Completed
  • Alzheimer's Disease
  • CAD106
  • +3 more
  • Costa Mesa, California
  • +30 more
Mar 2, 2021

Alzheimer's Disease Trial in Worldwide (Atorvastatin)

Completed
  • Alzheimer's Disease
  • Sun City, Arizona
  • +98 more
Feb 17, 2021

Apathy, Alzheimer's Disease Trial in Canada, United States (Methylphenidate, Placebo)

Completed
  • Apathy
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +9 more
Aug 7, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Scottsdale, Arizona
  • +210 more
Jul 1, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +195 more
Jul 1, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab)

Terminated
Has Results
  • Alzheimer's Disease
  • Newport Beach, California
  • +65 more
Jun 25, 2020

Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)

Terminated
Has Results
  • Alzheimer's Disease
  • Behavioral Variant Frontotemporal Dementia
  • Phoenix, Arizona
  • +134 more
May 15, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +85 more
Feb 18, 2020